Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Concomitant Detection of HER2 Protein and Gene Alterations by Immunohistochemistry (IHC) and Silver Enhanced In Situ Hybridization (SISH) Identifies HER2 Positive Breast Cancer with and without Gene Amplification

Figure 4

Stratification of IHC score 0/1+ tumors and amplification status by SISH to overall survival.

There is a tendency to shorter overall survival in HER2 amplified IHC score 0/1+ cases (Kaplan Meier curves).

Figure 4

doi: https://doi.org/10.1371/journal.pone.0105961.g004